pembrolizumab

Next generation cancer drugs that boost response to immunotherapy

By Sharon Kell|2017-06-07T14:36:16+00:007 Jun 2017|Drug treatments|

Drugs that target a protein called indoleamine 2,3-dioxygenase (or IDO [...]

Read More

Comments Off on Next generation cancer drugs that boost response to immunotherapy

• 

New drug epacadostat plus pembrolizumab combination shows promise in patients with advanced kidney cancer

By Sharon Kell|2017-06-06T13:22:46+00:006 Jun 2017|Drug treatments|

The results from a phase I/II clinical trial of epacadostat [...]

Read More

Comments Off on New drug epacadostat plus pembrolizumab combination shows promise in patients with advanced kidney cancer

• 

Immunotherapy combined with VEGF inhibitors for kidney cancer

By Sharon Kell|2017-05-22T11:21:21+00:0022 May 2017|Drug treatments|

In this video interview, Dr Shilpa Gupta, assistant professor, Haematology, [...]

Read More

Comments Off on Immunotherapy combined with VEGF inhibitors for kidney cancer

• 

A combination of immunotherapies may hold promise for kidney cancer

By Sharon Kell|2016-10-06T13:28:56+00:006 Oct 2016|Drug treatments|

A combination of the PD-1 inhibitor pembrolizumab (Keytruda) with another [...]

Read More

Comments Off on A combination of immunotherapies may hold promise for kidney cancer

• 

Eisai has started phase III clinical trial with lenvatinib as a potential first-line treatment for advanced kidney cancer

By Sharon Kell|2016-10-05T11:08:53+00:005 Oct 2016|Drug treatments|

This week saw the initiation of a global phase III [...]

Read More

Comments Off on Eisai has started phase III clinical trial with lenvatinib as a potential first-line treatment for advanced kidney cancer